Apoptotic dysfunction in STING-related pathways is found in T-cell-derived tumor cells, and mouse primary T cell leukemia is hyperresponsive to STING agonists, which indicates that STING agonists possess powerful therapeutic potential (19). Here, STING1 is linked to T-cell leukemia.